mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.002 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.003 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |